← Open Payments lookup

ISHANI DALAL: Open Payments

NPI 1013141803 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,098 in 41 payments from 16 companies in 2025. Trend: 2023 $1,900 · 2024 $893 · 2025 $1,098

Food & beverage: $1,098
CompanyPaymentsAmount
ABBVIE INC.10$360
Novo Nordisk Inc1$119
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$118
Otsuka America Pharmaceutical, Inc.4$97
E.R. Squibb & Sons, L.L.C.2$58
Janssen Pharmaceuticals, Inc3$57
Teva Pharmaceuticals USA, Inc.3$56
Vanda Pharmaceuticals Inc.2$39
Lundbeck LLC2$37
Axsome Therapeutics, Inc.1$35

Products named: QULIPTA, Wegovy, CAPLYTA, VRAYLAR, REXULTI, COBENFY, SPRAVATO, UZEDY.

Industry payments across IL — which companies pay providers there.